Sanofi (HAM:SNW) FFO


HAM:SNW Sanofi SA HAM:SNW
87 GF Score
Price €74.86
GF Value €106.66
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is Sanofi FFO?

FFO (Funds from operations) only applies to REITs.

HAM:SNW
87GF Score
Sanofi SA HAM:SNW
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Sanofi (HAM:SNW) Overvalued in 2026?

Based on GuruFocus' analysis, Sanofi stock appears to be undervalued. The current stock price of €74.86 is trading 29.8% below its estimated GF Value™ of €106.66. GuruFocus considers Sanofi to be Possible Value Trap.

Key valuation signals for HAM:SNW:

  • FFO:
  • GF Value™: €106.66 vs. price of €74.86 (29.8% below fair value)
  • GF Score™: 87/100 with 2 warning signs

No single metric tells the full story. See the HAM:SNW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sanofi Business Description

Address 46, Avenue de la Great Army, Paris, FRA, 75017
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
87GF Score

Get the complete analysis for HAM:SNW

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€74.86
Price
€106.66
GF Value